SEC FORM 4
$6,464.06
Lexeo Therapeutics, Inc. (LXEO)
Sale of 1,304 shares at $4.9571 per share.
Reporting Person Otero Jose Manuel · Officer Title Chief Operating Officer · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0002024096-26-000013 · filed 2026-08-19 · View filing →